A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line
- 1 April 2009
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1794 (4), 615-626
- https://doi.org/10.1016/j.bbapap.2009.01.006
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- DJ-1 Decreases Bax Expression through Repressing p53 Transcriptional ActivityPublished by Elsevier BV ,2008
- Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signalBiochemical and Biophysical Research Communications, 2007
- DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2Proceedings of the National Academy of Sciences of the United States of America, 2006
- Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinomaThe Journal of Pathology, 2006
- The Oxidation State of DJ-1 Regulates its Chaperone Activity Toward α-SynucleinJournal of Molecular Biology, 2006
- Proteomic analysis of hepatitis B virus‐associated hepatocellular carcinoma: Identification of potential tumor markersProteomics, 2005
- DJ‐1 has a role in antioxidative stress to prevent cell deathEMBO Reports, 2004
- Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growthOncogene, 2003
- DJ-1, a Novel Oncogene Which Transforms Mouse NIH3T3 Cells in Cooperation withrasBiochemical and Biophysical Research Communications, 1997
- Study of liver differentiation in vitro.The Journal of cell biology, 1981